BeStock  
Stocks › BHVN

Biohaven BHVN

US equityMarket cap rank #2714
$12.39 −$1.26 (-9.23%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $12.51 +0.97%
Open$13.26
Prev close$13.65
Day range$12.31 – $13.75
Volume2.39M
Market cap$1.87B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership94.3%+0.29 pts vs. prior quarter
Institutions holding343+0 vs. prior quarter
Insider trades (recent)37 buys / 9 sellsNet buying
Short interest9.94% of floatDays to cover 2.9 · as of 30 Oct 2026
Short-sale volume share14.6%5-day average of daily volume

Short-sale volume as % of daily volume

7%20%33%46%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$14.64M (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

−$13.3MSuper−$1.4MBig+$3.6MMid+$8.2MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 34.2% of shares outstanding.

Largest holders

  • BlackRock8.57%
  • Montanova Capital, LLC6.81%
  • Stifel Asset Management Corp.6.58%
  • John Childs6.54%
  • Janus Henderson Group plc5.68%
  • Woodline Partners LP5.07%
  • State Street Global Advisors4.55%
  • Infinitum Asset Management, LLC4.14%

By investor type

  • Mutual Fund46.66%
  • Hedge Fund35.93%
  • Individual/Insider10.94%
  • Private Company4.00%
  • Public Company3.91%
  • VC/PE Fund2.00%
  • Insurance Company1.09%
  • Government Pension Fund0.43%

Reported short interest has fallen from 11.80% to 9.94% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Nuveen Asset Management LLC Insurance Company 2026/Q3 +1,446,859 1.1%
Capricorn Fund Managers Limited Hedge Fund 2026/Q3 +764,801 0.5%
UBS Asset Management Mutual Fund 2026/Q3 +418,688 1.9%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +314,100 0.3%
Federated Hermes, Inc. Mutual Fund 2026/Q3 +197,087 0.3%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +1,164,539 0.9%
Warren Volles Individual/Insider 2026/Q3 +248,212 0.2%
Woodline Partners LP Hedge Fund 2026/Q3 +7,359,891 5.1%
AQR Capital Management Hedge Fund 2026/Q3 +2,152,024 2.7%
BlackRock Mutual Fund 2026/Q3 +1,988,178 8.7%
Rubric Capital Management LP Hedge Fund 2026/Q3 +1,721,493 1.1%
D. E. Shaw & Co., L.P. Hedge Fund 2026/Q3 +1,343,002 2.8%
Teachers Insurance and Annuity Association-College Retirement Equities Fund Mutual Fund 2026/Q3 +995,865 1.1%
Cormorant Asset Management, LP Hedge Fund 2026/Q3 +850,000 1.7%
Bank of America Corporation Public Company 2026/Q3 +721,765 0.9%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
14 Sep 2026 Kimberly Gentile Senior Vice President of Clinical Operations Other Derivative Acquisition +1,000 $12.34 1,000
5 Aug 2026 Infinitum Asset Management, LLC Initial Statement of Beneficial +0 – 6,250,000
8 Jul 2026 Warren Volles General Counsel & Chief Legal Officer Initial Statement of Beneficial +0 – 732,000
27 Apr 2026 John Childs Independent Director Other Derivative Acquisition +68,693 $9.61 68,693
27 Apr 2026 Julia Gregory Independent Director Other Derivative Acquisition +68,693 $9.61 68,693
27 Apr 2026 Robert Hugin Independent Director Other Derivative Acquisition +68,693 $9.61 68,693
27 Apr 2026 Gregory Bailey Independent Director Other Derivative Acquisition +68,693 $9.61 68,693
27 Apr 2026 Michael Heffernan Lead Independent Director Other Derivative Acquisition +68,693 $9.61 68,693
27 Apr 2026 Irina Antonijevic Independent Director Other Derivative Acquisition +68,693 $9.61 68,693
27 Apr 2026 Kishan Mehta Director Other Derivative Acquisition +68,693 $9.61 68,693
16 Mar 2026 Kishan Mehta Director Other Acquisition +17,342 – 22,662
16 Mar 2026 Kishan Mehta Director Other Disposition -17,342 – 22,662
26 Feb 2026 Matthew Buten Chief Financial Officer Other Derivative Acquisition +175,000 $11.52 175,000
26 Feb 2026 Vladimir Coric Chairperson & CEO Other Derivative Acquisition +550,000 $11.52 550,000
26 Feb 2026 Kimberly Gentile Senior Vice President of Clinical Operations Other Derivative Acquisition +175,000 $11.52 175,000
26 Feb 2026 Bruce Car Chief Innovation Officer Other Derivative Acquisition +175,000 $11.52 175,000
26 Feb 2026 George Clark Vice President Other Derivative Acquisition +50,000 $11.52 50,000
4 Jan 2026 Matthew Buten Chief Financial Officer Derivative Exercise and Sale -2,594 $9.93 195,652
4 Jan 2026 Matthew Buten Chief Financial Officer Derivative Exercise and Retained +1,656 – 195,652
4 Jan 2026 Vladimir Coric Chairperson & CEO Derivative Exercise and Sale -7,430 $9.93 3,849,354

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 15,012,928 9.9% 2.9
15 Oct 2026 17,899,310 11.9% 9.2
30 Sep 2026 19,053,695 12.6% 6.4
15 Sep 2026 20,449,005 13.5% 6.5
31 Aug 2026 19,000,171 12.6% 4.8
14 Aug 2026 17,819,010 11.8% 10.4

Discussion

No comments yet — be the first to weigh in on BHVN.

Sign in to join the discussion.

Scroll to Top